333D Limited Launches Pilot Program with BioScan 360 to Secure MRI Data with Blockchain
sydney, Australia – 333D Limited (AU:T3D) has announced a pilot collaboration with BioScan 360 to integrate blockchain technology into full-body MRI preventative healthcare services.Teh partnership aims to enhance patient data security and control by utilizing blockchain for the secure storage and management of medical imaging data,granting patients ownership of their records.
The initiative marks a important step for 333D into the rapidly evolving digital health sector, positioning the company at the forefront of preventative medicine and data privacy. 333D’s expertise in digital asset creation and management, including the application of artificial intelligence, will be crucial in developing and implementing this secure system. Successful completion of the pilot program will pave the way for national expansion of the service.
333D Limited specializes in digital capture and creation technologies, offering services encompassing digital imaging, 3D printing, and digital asset management across multiple platforms. The company leverages artificial intelligence to improve digital file creation processes.This collaboration with BioScan 360 builds upon that foundation, extending 333D’s capabilities into the healthcare space.
The partnership is expected to improve diagnostic accuracy and enable more personalized healthcare outcomes. by prioritizing patient data ownership, 333D and BioScan 360 aim to establish a new standard for security and clarity in medical imaging.
Key Metrics:
* Average Trading volume: 2,321,382
* Technical Sentiment Signal: Sell
* Current Market Cap: A$23.86M
For further facts on 333D Limited, visit TipRanks’ Stock Analysis page: https://www.tipranks.com/stocks/au:t3d
Disclaimer & Disclosure | Report an Issue
